The diagnosis of acute hepatitis C virus infection during seroconversion: an important therapeutic opportunity.

[1]  T. Santantonio,et al.  Natural course of acute hepatitis C: a long-term prospective study. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  E. Penner,et al.  Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load , 2003, Hepatology.

[3]  C. Trautwein,et al.  Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.

[4]  F. Ansaldi,et al.  Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen , 2001, Journal of Clinical Microbiology.

[5]  J. Crowe,et al.  The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection , 2001, Gut.

[6]  J. Neuberger,et al.  Clinical guidelines on the management of hepatitis C , 2001, Gut.

[7]  M. Krajden.  Hepatitis C virus diagnosis and testing. , 2000, Canadian journal of public health = Revue canadienne de sante publique.

[8]  B. Caldwell,et al.  Detection of Hepatitis C Core Antigen in the Antibody Negative ‘Window’ Phase of Hepatitis C Infection , 2000, Vox Sanguinis.

[9]  J. Goudsmit,et al.  Different Hepatitis C Virus (HCV) RNA Load Profiles Following Seroconversion among Injecting Drug Users without Correlation with HCV Genotype and Serum Alanine Aminotransferase Levels , 1998, Journal of Clinical Microbiology.

[10]  J. Gross.  Clinician's guide to hepatitis C. , 1998, Mayo Clinic proceedings.

[11]  M. Alter.  The epidemiology of acute and chronic hepatitis C. , 1997, Clinics in liver disease.

[12]  M. Edgar.  Tackling rugby injuries , 1995, The Lancet.

[13]  S. Yagi,et al.  Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection. , 2001, Clinical laboratory.

[14]  M. Beld,et al.  Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. , 1999, Blood.

[15]  R. Laufs,et al.  High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. , 1997, Intervirology.

[16]  J. Esteban,et al.  Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention. , 1992, Progress in liver diseases.